← Back to Search

Unknown

ADX-629 for Chronic Cough

Phase 2
Waitlist Available
Research Sponsored by Aldeyra Therapeutics, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 1 - 14 of each treatment period
Awards & highlights

Study Summary

This trial is testing a new drug to see if it is safe and effective for people with chronic cough.

Eligible Conditions
  • Chronic Cough
  • Chronic Bronchitis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from baseline to the end of each 14-day treatment period (day 1 - 14 of each treatment period)
This trial's timeline: 3 weeks for screening, Varies for treatment, and from baseline to the end of each 14-day treatment period (day 1 - 14 of each treatment period) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of participants with adverse events (AEs)
Secondary outcome measures
Change from baseline in awake cough frequency after 2-week treatment period

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: ADX-629Experimental Treatment1 Intervention
Subjects will be randomized to receive ADX-629 300mg tablets administered orally twice a day for 14 days.
Group II: PlaceboPlacebo Group1 Intervention
Subjects will be randomized to receive matching placebo tablets administered orally twice a day for 14 days.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
ADX-629
2021
Completed Phase 2
~110

Find a Location

Who is running the clinical trial?

Aldeyra Therapeutics, Inc.Lead Sponsor
29 Previous Clinical Trials
3,982 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who is eligible to join in on this research project?

"This medical trial seeks 50 adult subjects (ranging from 18 to 80 years old) with a chronic, unexplainable cough that has not been remedied by medication. Selected participants must also be non-pregnant/breastfeeding and agree to use an effective form of contraception for the duration of the study as well as cease using antitussive medications during this time."

Answered by AI

Are individuals over the age of 50 being sought out for enrollment in this research?

"This research is recruiting participants who are aged 18 and above, but below 80 years of age."

Answered by AI

Is enrollment still available for the current clinical trial?

"According to the information on clinicaltrials.gov, this experiment is presently recruiting volunteers. The initial posting for this research was on April 7th 2022 and it was last revised on September 21st 2022."

Answered by AI

How many health care facilities are conducting this trial?

"This trial is being operated from the Florida Pulmonary Research Institute LLC in Winter Park, as well as Allergy Associates Medical Group Inc. in San Diego and Allergy & Asthma Associates of Santa Clara Valley Research Center located in San Jose Oklahoma amongst other 10 institutes."

Answered by AI

Is ADX-629 a risk-free substance for human consumption?

"Our team at Power gave ADX-629 a score of 2 on the safety scale, as there is limited evidence from Phase 2 trials to support its safety profile but no efficacy data."

Answered by AI

To what extent is this study recruiting participants?

"This study necessitates at least 50 individuals that meet the criteria for inclusion. Potential participants have the option of enrolling in this trial via Florida Pulmonary Research Institute LLC located in Winter Park, FL and Allergy Associates Medical Group, Inc., situated in San diego ca."

Answered by AI

Who else is applying?

What state do they live in?
North Carolina
How old are they?
18 - 65
What site did they apply to?
Charlotte Lung & Health/American Health Research
What portion of applicants met pre-screening criteria?
Met criteria
Did not meet criteria
Recent research and studies
clinicaltrials.govStudy
A Clinical Trial to Evaluate the Safety and Efficacy in Subjects With Chronic Cough
2022. "A Clinical Trial to Evaluate the Safety and Efficacy in Subjects With Chronic Cough". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05392192.
~17 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top